Treatment of colon cancer in rats with rMuTNF and the interferon-inducer bropirimine
✍ Scribed by R. L. Marquet; R. W. F. Bruin; A. M. M. Eggermont; J. Jeekel
- Publisher
- SP Birkhäuser Verlag Basel
- Year
- 1989
- Tongue
- English
- Weight
- 127 KB
- Volume
- 26
- Category
- Article
- ISSN
- 1420-908X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract A spontaneous non‐immunogenic transplantable liposarcoma in BN rats was found to be sensitive to the antitumor effects of rat fibroblast interferon (RIF) when it was administered from the day of tumor implantation onwards. Treatment with RIF starting at 7 days after implantation was not
## Abstract In this seminar, we describe 1) the immunogen TAA used for lung cancer immunotherapy and the immunogen TAA used for colon cancer immunotherapy, 2) the methods used in the administration of these immunogens in clinical trials of specific active TAA immunotherapy, 3) the results of clinic